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Chapter 4 0 
Eliminating Interstitial Cells 
with Nitrogen Mustard 
Charles N. David 
PURPOSE 
To remove interstitial cells and differentiating nematoblasts from hydra 
leaving a shell of epithelial and gland cells. 
INTRODUCTION 
Treatment of hydra with nitrogen mustard (NM) causes the rapid 
elimination of interstitial cells and differentiating nemotoblasts from the 
tissue (Diehl and Burnett, 1964). Such hydra have been used to investigate 
the role of interstitial cells in budding and regeneration (Diehl and Burnett, 
1965a, b ) . In addition, NM-treated hydra have been used as feeder layers for 
the culture of interstitial cells added to them by grafting (Diehl and Burnett, 
1966) or reaggregation techniques (David and Murphy, 1977). The method, 
described here for H y d r a attenuata, is essentially that of Diehl and Burnett 
(1964), who used H y d r a pseudoligactis and H y d r a p i r a r d i . 
Charles N . David • Department of Molecular Biology, Albert Einstein College of Medicine, 
Bronx, New York. 
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COMMENTS 
N M is a potent alkylating agent capable of adding ethyl residues to 
nucleic acids including DNA (see Goodman and Gilman, 1974, for review). 
It is strongly cytotoxic to proliferating cells; nonproliferating or slowly 
proliferating cells appear to be less affected. 
N M acts on cells at any stage of the cell cycle. Progression through the 
cycle, however, is usually blocked in the G 2 (premitotic) phase. Cells 
blocked in G 2 continue synthesizing RNA and protein and often become 
enlarged due to unbalanced growth. 
Treatment of hydra with 0.01% N M for 10 min leads to the dis-
appearance from hydra tissue of interstitial cells and differentiating nema-
toblasts over the next 4-8 days. This process can be easily monitored by 
observing interstitial cells in whole mounts of hydra stained with Toluidine 
Blue (Diehl and Burnett, 1964) or by counting interstitial cells in macera-
tions of treated animals (David, 1973). Subsequently the number of dif-
ferentiated nerves and nematocytes also declines. By comparison, the epi-
thelial and gland cell populations appear to be less affected. Five days after 
N M treatment, hydra consist of a shell of epithelial and gland cells, and in 
this condition they survive for 4 weeks or longer. 
The effects of N M on hydra cells are best explained with reference to the 
proliferation kinetics of hydra cell types. Interstitial cells are rapidly pro-
liferating cells with generation times of 18-27 hr (Campbell and David, 
1974). They are rapidly killed by N M and eliminated from hydra tissue, 
probably by phagocytosis by epithelial cells. Epithelial cells have cell 
generation times of 3 days in well-fed hydra and more than 6 days in starving 
hydra (David and Campbell, 1972). They are also killed by N M , but because 
of their longer cell cycle they survive longer than interstitial cells and thus 
give rise to animals consisting only of epithelial cells. Gland cells have a 
similar cell cycle to that of epithelial cells and also survive for long periods in 
NM-treated hydra. 
MATERIALS 
Two percent (w/v) sodium thiosulfate and 0.01% N M (Sigma Chemical 
Co.,). Special precaution: N M is toxic and should be handled with care. 
Carry out as much of the procedure as possible in a fume hood. In addition, 
have 1-2 liters of 2% sodium thiosulfate Solution available to detoxify any 
spilled N M Solution as well as any unused reagent. 
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PROCEDURES 
Because N M is unstable in water, prepare the reagent from the dry 
powder immediately before use. Add N M to hydra at a final concentration of 
0.01%. Mix the Solution thoroughly by stirring with a pipet, taking care that 
all hydra are in Suspension and not stuck to the sides of the dish. After 10 min 
allow the hydra to settle, decant the Solution and fill the dish with fresh 
medium. Repeat the washing procedure four times to stop the action of N M 
on the hydra. Thereafter wash the hydra at least once each day in order to 
remove dead hydra and debris from the dish. 
After N M treatment hydra can be fed for about a week until their 
nematocytes are depleted (Diehl and Burnett, 1964). However, feeding 
stimulates cell cycling and accelerates the death of treated animals. If the 
purpose of N M treatment is to prepare hydra free of interstitial cells, then 
one feeding after N M treatment appears to optimally stimulate the dis-
appearance of interstitial cells without adversely affecting the survival of the 
host animal. 
A final concentration of 0.01% N M is usually effective in completely 
eliminating interstitial cells from tissue without immediately destroying the 
animals. However, the precise concentration of N M required to eliminate 
interstitial cells varies slightly between batches of N M . Thus, it is useful to 
test several concentrations when using a freshly opened bottle of N M . If, 
after prolonged use, the N M in a bottle loses some of its potency, increase the 
concentration of N M used in experiments. However, do not use more N M 
than necessary because it does destroy epithelial cells and thus may 
noticeably shorten the survival of treated animals. 
SPECIAL APPLICATIONS 
NM-treated hydra free of interstitial cells are useful hosts in which to 
study the fate of interstitial cells added to them by grafting or reaggregation 
techniques. When normal hydra tissue is grafted into NM-treated tissue, 
interstitial cells migrate from the normal tissue into the N M tissue, where 
they proliferate and differentiate normally (Diehl and Burnett, 1966). In-
terstitial cells can also be introduced into N M tissue by preparing aggregates 
from dissociated NM-treated hydra (David and Murphy, 1977). Such 
aggregates regenerate normal hydra structures. When small amounts of 
normal tissue are dissociated and added to such N M aggregates, the added 
interstitial cells proliferate and differentiate normally. The number of cells 
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seeded in such aggregates can be easily controlled, and the aggregates 
function effectively as tiny tissue culture dishes (see Chapter 33). 
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Dithioerythritol, 335 
Dithiothreitol, 338, 335 
D M S O , see Dimethylsulfoxide 
D N A 
bacterial, 189 
content of hydra, 162 
and hydroxyurea, 292 
DNase , 374, 376 
Doubling time of cells, 32, 158 see Growth 
Dye, see Stain 
Ecology dish, 263 
Ectoderm, 5, 108, 138, 267-271 
autoradiography, 119 
and carbon particle, 183 
-endoderm chimera, 273-277 
formation, 268 
isolation, 267-271 
by mechanical method, 269-270 
by perfusion method, 269 
Egg. 8 
hatching time, 214 
stimulating formation, 71 
Ehrlicrfs hematoxylin stain, 124, 125, 128 
Electrode, 429-433 
Electron microscopy 
scanning, see Scanning electron microscopy 
transmission, 87-94 
preparation for, 87-90 
Electrophoresis on acrylamide gel, 338 
Electrophysiology, 429-451 
Embeddingspecimen, 88, 89, 92, 123-124 
Endoderm, 5, 138, 267-271 
-ectoderm chimera, 273-277 
456 Index 
Endoderm (cont.) 
formation, 268 
isolating, 267-271 
peeling off, 270 
Endosymbiont, see Alga , endosymbiotic 
autotrophic, 407 
Enteron, 101 
see Coelenteron 
surface, 109 
Enzyme assay, 361-371 
oü-well method, 367-377 
Eosin, 123, 128 
Epidermis, 5 
Ethanol, 117, 118, 122, 123, 128, 174, 198, 
199 
Epizoötological research, 417-425 
Evans blue, 132, 133, 136 
carcinogenic, perhaps, 137 
Everting whole hydra, 270 
Extrusion mechanism for nematocyst, 331 
Fast green stain, 127 
Feeder-layer technique, 261 
Feeding 
forced, 304 
pipet, 288 
radioactive tissue, 194-195 
response, 443-451 
activator, 443-451 
potency, 447-449 
bioassay for, 443-451 
inhibitor, 443-451 
competitive, 448-450 
noncompetitive, 451 
and potassium ion, 450 
quantification, 447 
Ferric alum, 127 
Ferritin, 105 
Feulgen stain, 124, 125, 127, 162, 166 
method described, 127 
and mitotic cell, 118-119 
reagent, 162 
Fiddler crab, 342, 345, 348 
F i l m , Photographie, 146, 147 
Filter, micropore, 197-198, 205-206 
Fixative, 87-90, 107, 121-129, 166, 174 
Fluorescent microscopy, 133 
Fluorometer, 404 
Foot (basal disk), 6-9, 231 
activator 
assay, 316-318 
Foot (basal disk), activator (cont.) 
defined, 318 
purification, 323 
formation 
activation, 238-241, 243 
frequency of, 232, 234, 236 
inhibition, 238-241, 243 
gradient, 244-245 
optimization of activation-inhibition 
level, 244-251 
uncertainty, Statistical, 241-247 
inhibitor, 318 
assay, 319 
defined, 318 
purification, 323 
sectioning, 124 
Formalin, 402 
Forced feeding, 304 
Fractionation of tissue, 197-203 
Freeze-drying, 362-363 
Freeze-etching, 105-115 
Freeze-fracture, 105-115 
Fructose-l,6-diphosphate, 305-307 
Fungus, 41 
G2-Phase, 160-161,291 
Gastric cavity, 5 
Gastrodermis, 5 
Gentamicin, 257 
Glass needle, 225-227 
Glass suetion electrode, 431-432, 439 
Gluconic acid, 412 
Glucose oxidase, 411 
Glucose oxidase and peroxidase, 412 
Glucosidase, 412 
Glutaraldehyde, 89, 90, 96, 106 
Glutathione, 195, 269, 446 
and mouth-opening, 269 
Glutinant 
stereoline, 12 
streptoline, 12 
Glycerol , 128 ,332 ,393-394 
Gonad development, 213 
Gonocyte, meiotic, 14 
Gradient, morphogenic, 234 
Grafting, see Transplantation 
dish, 225-226 
tissue, 1,2, 225-233, 274, 299, 301 
Granule, intramembranous, 110, 111, 114 
Green hydra, see Hydra 
Growth 
Index 457 
Growth (cont.) 
count. 49-50 
curve, 158 
rate, 32, 47-52 
calculation, 51 
clonal, 48-52 
doubling time, 32, 158 
precautions, 51-52 
Gut, 5 
see Coelenteron, Enteron 
Hair point, 362 
Handling hydra, 17-83 
Hatching time of egg, 214 
Head, 6, 7 .231,311 
activation-inhibition model, 238 
defined, 313 
gradient, 233, 235 
optimization level, 244-251 
uncertainty, Statistical, 241-247 
activator 
assay 
fast, 313-314 
Standard, 321-313 
purification, 321, 323 
formation, frequency of, 232, 234, 
236. 238 
inhibitor 
assay 
alternative, 315-316 
Standard, 314-315 
defined, 315 
purification, 323 
reduced, 231 
Heidenhain Susa fixative, 125 
Hemacytometer, 404 
Hematoxylin, 128, 166 
Ehrlich's, 124, 125 
iron, 124-127 
Hemolysis 
assay, 349-353 
curve, 352 
data, plotted, 352-353 
microtitration, 353 
percentage of, 352 
plotting data, 352-353 
spectrophotometry of, 351 
treatment, mathematical, 351-353 
see Rat red blood cells 
Hexadecane, 368 
Histology, 87-140 
Hoechst 3 3 2 5 8 , 133-135 
carcinogenic, 134 
Hydra, epithelial, 281 
cloning, 286 
culturing, 287-290 
definition, 287 
feeding technique, 288, 289 
by force, 288-290 
formation, 287 
by colchicine, 287 
by gamma-irradiation, 287 
by inbreeding, 287 
inserting shrimp into, 288 
maintaining, 290 
mouth-opening, 288 
Hydra, green 
oxygen evolution, 383-387 
photosynthesis, 386 
respiration, 383-387 
H y d r a species, 19-28 
H . a m e r i c a n a , 23, 25 
H . attenuata, 2 2 , 26, 154, 175, 235, 
281-286, 292, 295-297, 299, 304, 
312,450 
H b r a u e r i , 23, 25 
H . canadiensis, 25 
H c a r n e a , 23, 26, 27 
H . c a u l i c u l a t a , 23, 26, 27 
H . c i r c u m i n a t a , 2 5 
H f u s c a , 2 5 
H . hadleyi, 22-24 
H hymanae, 22-25 
H . l i t t o r a l i s , 23, 27, 31, 32, 235-237, 
336-337, 341-346 ,419 ,445 
H . m a g n i p a p i l l a t a , 26, 211, 213, 281 
H . m i n i m a , 23, 25 
H oligactis, 23-26, 267, 373 
H . ovata, 2 5 
H . p a r v a , 2 5 
H p i r a r d i , 26, 299, 450 
Hpseudoligactis, 23-26, 267, 299, 329, 
418 ,419 
H robusta, 25, 26 
H . rutgerensis, 23, 26, 27 
H stellata, 2 5 
H . utahensis, 23, 25 
H . viridis, 22, 154, 213, 244, 247, 267, 
281, 295-297, 329, 394-396, 411, 
412 ,418 ,419 , 450 
H viridissima, 22-24 
H vulgaris, 23, 26, 27 
458 Index 
H y d r a species (cont.) 
criteria for identifying, 19 
literature on systematics, 20 
see specific aspects of hydra 
Hydramoeba hydroxena, 18 ,417-418 
growth, 420-421 
host mortality, 421 
hydra System, 417 
infection rate, 423 
stock culture, 418-419 
survivorship curve method, 422-423 
Hydranth, 5, 6 
count of, 49-50 
Hydroxyurea, 281, 291-294 
and cell population, 293 
and D N A , 292 
Hypostome, 5, 6, 92, 100, 102, 112, 113, 
124,231 
Immunofluorescence, indirect, 138-139 
Immunoglobulin (goat anti-mouse), 133 
Inbreeding, 287 
depression, 2, 3 
sexual, 211-221 
see Mutant 
India ink marker, 183-186, 274 
Infection, bacterial, see Bacteria 
Inhibition, see Foot, Head 
Injecting hydra, 189, 400 
Interference microscopy, 119 
Iron hematoxylin stain, 124, 125, 127 
Irradiation 
gamma-ray, 287, 303-304, 396 
Isocitrate dehydrogenase, 368 
microassay for, 368 
Isorhiza, 217 
atrichous, 12, 173 
holotrichous, 12, 173 
Isotope technique, 189-203 
K e r o n a pediculus, 18, 424 
Labeling 
double, 160 
by feeding, 193 
by injection, 193-196 
radioactive, 158-159, 189-207 
with , 4 C 0 2 , 196 
N-Lauroyl sarcosine, 328 
Lavdowsky's fixative, 118, 119, 122, 124, 
166 
Lead nitrate stain, 171-176 
preparation, 172, 174 
L-a-Lecithin, 354 
Leeuwenhoek, Anthony van, 1 
Lethality 
bioassay, crustacean, 348-349 
L D 5 0 , 349 
Light microscopy, 117-130 
Log-linear model, 246 
Lyophilization, see Freeze 
M Solution, 31 
Maceration technique, 153-156, 166, 401 
autoradiography, 155 
counting cells, 154-155 
fixative, 153 
for Single cells, 153-156 
Solution for, 153, 402 
staining, 156 
Macrophotography, 143-149 
Maertin's Solution, 412 
Magnesium uranyl acetate, 89 
Mallory's triple stain, 124, 125, 129 
one-step method, 129 
Maltose 
of alga, endosymbiotic, 411 
assay, spectrophotometric, 411-413 
Mcllwaine 's buffer, 412 
Medium, see Culture Solution 
Membrane. 110, 111 
Mercaptoethanol, 335, 338 
Mesolamella, 2 , 5 , 102, 103, 112-114, 186. 
281 
isolation, 327-329 
properties, 327-329 
sticky, 328 
Mesoglea, see Mesolamella 
Methanol, 318, 321, 404 
3-Methyl-2-benzothiazolinone hydrazone 
hydrochloride, 412 
Methylene blue staining, 131 
of nematocyst, 119 
Methylphenyldiazenecarboxylate, 450 
Methylsalicylate, 123 
M e t r i d i u m sp.,see Sea anemone 
Microassay, 367 
precautions, 370 
Microelectrode, glass capillary as, 429-432, 
435 
Microinjection pipet, 399-400 
Micropipet, 184 
Index 459 
Microscalpel, 362 
Microscopy 
bright field. 181 
electron, 87-104 
fluorescent, 133 
interference, 119 
light 
phase. 169, 251 
polarization, 119 
scanning electron, 95-104 
transmission electron, 87-94 
Microtitration 
dilution. 353 
plate, 353 
Microtubule, 1, 2 
Mineral o i l . 368 
Mitosis 
duration, 161 
index, 161, 165-168 
labeled as a technique, 160-161 
Mitotic index, 161, 165-168 
defined, 165 
for growth estimation, 165 
and growth rhythm, 167 
Morphogen, 311-324 
assay, biological, 312-318 
for activator, 312-314,316-318 
for inhibitor, 314-316,318 
purification on column, 318-323 
Morphogensis, 311-324 
control, chemical, 311-324 
Morphology, 5-14 
Mount, whole. 117-120, 166-167, 174-175 
Mouse, 345 
C A F strain, 342 
lethality bioassay, 349 
L D 5 0 , 349 
liver, radioactive, 195 
tissue, radioactive, 195 
Mouth, 7 
-opening, 269, 288 
Muscle mat, 9 
Mutant, 211-221 
cell types in altered proportions, 215,219 
developmental, 21 1 
inbred. 211-221 
male, sterile, 270 
maxi, 214 
mini, 214 
multiheaded, 215-216 
nematocyst-deficient, 215, 217 
Mutant (cont.) 
regeneration-deficient, 215 
twisted column, 214, 216 
Mycostatin, 212 
Myoneme, 102, 103, 112, 114 
Narcosis, see Anesthesia 
Naupl i i , see A r t e m i a s a l i n a 
Neck, 6, 7 
Nematoblast, 11, 160, 219, 291-294, 299, 
300 
lead nitrate-thioacetic acid stain, 171-176 
and microtubule, 2 
numbers of, 169-182 
Nematocyst, 24, 90, 91, 96, 98, 108, 304, 
305,327-387 
assay for 
hemolysis, 349-353 
lethality, 348-349 
phospholipase, 353-355 
capsule, 2, 177, 335-339 
composition, 337-338 
discharged, 331-333 
mechanism for, 331 
dissolution, 337 
examination, 20-21 
extrusion, 331 
medium for, 331 
isolation, 327-328 
isorhiza, holotrichous, 21 
number. 169-182 
properties, 327-387 
in sea anemone, 331-333 
Suspension, 176-178 
in tentacle, 217 
thread protein, 335 
toxin, 331 
type 
desmoneme, 21 
isorhiza 
atrichous, 21 
holotrichous, 21 
photomicrograph, 170 
stenotele, 21 
undischarged, 331-333 
venom, 341, 347-358 
Nematocyte. 12, 162, 219, 301, 305-307 
on body column, 179-181 
and interference microscopy, 119 
and microscopy, bright-field, 181 
numbers, 169-182 
460 Index 
Nematocyte, numbers (cont.) 
reduced, 305-307 
Suspension, 176-178 
in tentacle, 176-178 
and toluidine-blue stain, 179 
Nembutal, 122 
Nerve 
cell, 13,295-297 
net, 14 
Neubauer cell counting Chamber, 178, 251 
Neuron, sensory, 13 
Neutral red, 131 
Ni le blue sulfate, 131, 132 
Nipple, 7 
Nitrogen mustard, 258, 261-268, 275-276, 
299-302 
and cell cycle, 299-302 
precautions, 277 
treatment, 276 
Oöcyte , 8, 14 
Oögonium, 14 
Operculum, 108 
Optimization method, 244 
Orange G , 129 
Osmium tetroxide, 344 
dangers of, 345 
Ovum, 14 
Ovary, 7 
Oxygen 
consumption measured, 383-386 
electrode, 383 
calibration, 384 
Chamber, 387 
instability, 386 
evolution, 386-387 
of green hydra, 383-387 
and photosynthesis, 386 
Paraffin, 121, 133 
Paraformaldehyde, 89, 90, 97, 106 
Parasites of hydra, 18 
see also Anchistropus, H y d r a m o e b a , 
K e r o n a , T r i c h o d i n a 
Peduncle, 6, 7 
Pelmatohydra oligactis, 32 
P'. pseudoligactis, 32 
Penicillin G , 212 
Phagocytosis, 183, 300 
Phase microscopy, 169, 251 
Phenol, 374 
Phenol {com.) 
-Chloroform extraction of R N A , 373-377 
Phenol red, 35-37 
Phospholipase 
assay 
manometric, 353-355 
titrimetric, 355 
carbon dioxide release, 354 
thin-layer chromatography, 355-356 
in venom, 353 
Phosphorus method, 356 
Phosphotungstic acid, 129 
Photobleaching, 394-395 
Photography, see Macrophotography 
Photoöxidation, 338 
Photosynthesis of green hydra, 386 
Phototaxis, 18 
in an eyeless animal, 1 
Physalia sp. venom, 347 
Poisson distribution, 264 
Polarization microscopy, of muscle process, 
119 
Polyethylene needle, 190-191 
Polyp, 5, 68, 69 
Pore, aboral, 7 
Portugese man-of-war, see Physalia sp. 
Potassium ion, and feeding response, 450 
Potassium acetate, 374-376 
Potential 
spontaneous, 429-435 
transepithelial, 435-436 
Procamborus c l a r k i i , see Crayfish 
Procedures, analytical, 361-387 
Pronematocyst, 11 
Protein 
analysis, colorimetric (Lowry et a l . ) , 
379-381 
Protozoon, 257, 263 
Pyridine nucleotide fluorescence, 367 
Quantification (numbers), 175 
and feeding response, 447 
pipetimetric, 64-65 
turbidimetric, 64 
Quartz fiber ultramicrobalance, 363-367 
calibration, 366 
precaution, 367 
use, 366 
Quartz filter, 365 
Radioactive hydra, 193-196 
Index 461 
Radioactivity 
assay, 199, 202 
calculation, 200, 202 
percentage, 202 
Radioautography, see autoradiography 
Rat red blood cell, 349 
Razor blade fragment as knife, 226, 228 
holder for, 228 
Reaggregation, 299, 301 
Red blood cell 
absorbancy unit, 351 
hemolysis, 349-353 see Hernolysis 
preparation, 349, 350 
standardizing, 350-351 
washing, 350 
Reflex camera, 144 
Regeneration, 1, 299 
after amputation, 218 
Relaxant, 122 
Reproduction, asexual, 1, 53 
Respiration of green hydra, 383-387 
Rifampicin, 212, 257, 282, 288 
R N A , 373-377 
buffer, 374 
electrophoresis, 376 
extraction by phenol-chloroform, 373-377 
fractionation, 87, 88, 376 
purification, 375-376 
ribosomal, 374 
RNase, 375 
Scanning electron microscope, 95-104 
resolution, 95 
x-ray microanalysis, 95 
Schiff reagent, 119, 127 
Sea anemone, acontiate, 331-333 
A i p t a s i a p a l l i d a , 332, 333, 347, 353 
D i a d u m e n e sp., 332 
M e t r i d i u m sp., 332 
nematocyst venom, 347 
neurotoxin, 356 
sodium current, 356 
Sectioning hydra, 123-124 
S E M , see Scanning electron microscopy 
Separation gel of acrylamide, 337 
Sesame oi l , 344 
Sexually differentiated hydra, 71-77 
methods for, 73-76 
Shock, electric, 306 
Chamber for, 307 
Size of hydra, 67-70 
Sodium cacodylate, 89, 90, 106, 171 
Sodium citrate, 332 
Sodium dodecyl sulfate, 374, 403 
Sodium pentobarbital, 106 
Sodium thiosulfate, 300 
Solutions, culture, 30-31 
Species of H y d r a , see H y d r a species 
Specimen Chamber, 147-148 
for photography, 148 
for shock, electric, 307 
Spermatid, postmitotic, 14 
Spermatocyte, 14 
Spermatogonium, 14 
Spermatozoa, 14 
S-phase ofcel l cycle, 159-160,291 
Spurr's embedding medium of low viscosity, 
88 
Square wave 
pulse, 357 
stimulator, 306 
Squash preparation, 336-337 
Stacking gel of acrylamide, 337 
Staining, 88, 124-125 
maceration for, 156 
procedures, 118 
of tissue, 174 
vital, 1, 131-140 
by feeding 
colloidal carbon, 132 
colored food, 131 
fluorescent dye, 132 
Stains 
acid fuchsin, 129 
aniline blue, 129 
Biebrich scarlet, 128 
eosin, 123, 128 
Evans blue, 132, 133, 136, 137 
fast green, 127 
Feulgen, 118, 162 
application, 118-119, 124-125, 127, 
166 
fluorescent, 132 
hematoxylin, 124, 125, 128, 166 
India ink, 274 
iron hematoxylin, 124-127 
lead nitrate, 171-176 
Mallory 's triple, 124, 125, 129 
methylene blue, 119, 131 
neutral red, 131 
Nile blue sulfate, 131, 132 
orange G , 129 
462 Index 
Stains (cont.) 
phenol red, 35-37 
thiolactic acid lead, 119,171-176 
toluidine blue, 118, 124, 125, 129, 179, 
180 
see also Dye 
Stalk, 6 
see Peduncle 
Stenotele, 12, 21, 172, 173, 178, 217 
dissolution, 337 
reduction in number, 306 
Stereoline glutinant, 12 
Streptoline glutinant, 12 
Streptomycin, 265 
Succinoxidase inhibitor, 341-346 
Susa fixative, 122 
Symbiont, green alga, 394, 401-405 
Symbiosis, 388-413 
Taeniola, 9 
Tannic acid, 92 
Teflon block, 368 
Tentacle, 7, 231 
isolation, 176-177 
whorl, 6 
Testis, 7, 81 
induce formation, 71 
Theca, 8 
Thioglycolate, 335, 338 
Thiolactic acid lead staining, 171-176 
of nematoblast, 119 
Thiol Solution, 336, 337 
Thymidine, labeled, 132, 158-162 
injected into hydra, 189 
Tissue 
chimera, preparation of, 275-279 
culturing stem cells, 261-266 
dissociation, 154, 251-259 
ectoderm, 267-271 
endoderm, 267-271 
enzyme assay, 361-271 
grafting, 1, 2, 225-233, 274, 299, 301 
layer, viable 
separating, 267-271 
maceration, 153-156 
manipulation, 225-279 
microgram quantities, weighed out, 
361-371 
Organization, 225-279 
pieces of, 155 
radioactive, 193-196 
Tissue. radioactive (cont.) 
fractionation, 197-203 
regeneration, 1 
transplanting, 225-249 
Toluidine blue stain, 1 18, 124, 125, 129, 
179, 180 
and interstitial cell, 118 
Track plate, nuclear, 205, 206 
Transection, 81-82 
Translocation, of reduced organic carbon 
Compounds, 407-409 
Transplantation 
axial, 231 
experiments, 235-236 
offoot, 231 
ofhead, 231 
lateral, 230, 231 
property, intrinsic, 234 
quantitative Interpretation, 233-249 
Tray method for culturing hydra, 54, 56-60 
cleaning, 56-58 
feeding, 56 
precaution, 59-60 
Treatment, chemical, 258 
Trembley, Abraham, 1 
M e m o i r e s ( 1744), 1 
Trichloracetic acid, 198-199 
T r i c h o d i n a pediculus, 424 
Trimethoprim, 395 
t-Test, 312 
T X , see 6-Carboxyfluorescein 
U c a pugilatov, see Fiddler crab 
Uncertainty, Statistical. 241-248 
Urethane, 122. 174 
Vital staining, 131-140 
review of, 131-132 
see also Dye, Stain 
Van Harreveld Solution, 356 
Variable, redundant, 245 
Vertical plate method for culturing hydra, 
54-56,60-62 
care of tank, 61 
feeding, 61 
precaution, 61-62 
seeding, 60 
Villus, endodermal, 11 
Volvent, 12 
Warburg flask, 194 
Index 463 
X-ray microanalysis, 95 Zenker fixative, 122 
Xylene. 117, 118 Zymogen, 14 
